Business
2 blue chip ASX 200 shares that could be strong buys
If you’re aiming to build a balanced portfolio, having a few blue chip ASX shares in there could be a smart move.
But which blue chip ASX 200 shares should you buy? Two that are highly rated are listed below:
The first blue chip ASX 200 share to look at is biotechnology giant CSL.
CSL has a focus on rare and serious diseases through its CSL Behring business and influenza vaccines through its Seqirus business.
CSL Behring has a wide range of innovative therapies. These are used to treat immunodeficiencies, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency, and neurological disorders. Whereas Seqirus has a broad range of flu products meeting the needs of different populations around the world.
While…
-
Noosa News23 hours agoUnderstanding the conflict conundrum – Proctor
-
Noosa News24 hours agoQld CFMEU labels David Crisafulli’s vow to rid state of union ‘offensive and dangerous’
-
Business23 hours ago9 ASX shares including Nuix and PolyNovo dumped from ASX 200
-
Noosa News24 hours agoThree Bartender-Approved Peanut Butter Whisky Cocktails